Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.
Overview & Synopsis
Open access biomedical research article published in J Eur Acad Dermatol Venereol.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study. |
|---|---|
| Author / Organization | Kern JS, Thomsen SF, Kokolakis G, Podda M, Jemec GBE, Gebauer K, Zachariae C, Frew J, Fernandez-Peñas P, Bechara FG, Beissert S, Malandkar S, Scalzo-Inguanti K, Nandy P, Sukumar S |
| Subject & Discipline | J Eur Acad Dermatol Venereol |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-6321 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |